Holen Sie sich die Stockscreener-App
455.75
1.66%
8.375
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt VRTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$447.38
Offen:
$446.86
24-Stunden-Volumen:
950.46K
Relative Volume:
0.65
Marktkapitalisierung:
$115.39B
Einnahmen:
$11.74B
Nettoeinkommen (Verlust:
$3.68B
KGV:
32.12
EPS:
14.1888
Netto-Cashflow:
$3.34B
1W Leistung:
+0.61%
1M Leistung:
+8.02%
6M Leistung:
+1.43%
1J Leistung:
+14.66%
1-Tages-Spanne:
$445.51
$455.12
1-Wochen-Bereich:
$445.41
$459.05
52-Wochen-Spanne:
$362.50
$519.68
Vertex Pharmaceuticals Inc Stock (VRTX) Company Profile
Firmenname
Vertex Pharmaceuticals Inc
Sektor
Branche
Telefon
(617) 341-6393
Adresse
50 NORTHERN AVENUE, BOSTON, MA
Vergleichen Sie VRTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRTX
Vertex Pharmaceuticals Inc
|
454.81 | 113.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
769.40 | 78.69B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
403.73 | 52.32B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
859.59 | 52.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.76 | 35.52B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vertex Pharmaceuticals Inc Stock (VRTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-09-03 | Eingeleitet | Raymond James | Mkt Perform |
| 2025-08-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-05-07 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-02-12 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2025-02-11 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2025-01-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-20 | Bestätigt | H.C. Wainwright | Buy |
| 2024-12-19 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-12-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-11-14 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-10 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-08-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-06-27 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-06 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-02-02 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-01-31 | Herabstufung | Maxim Group | Buy → Hold |
| 2024-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2024-01-24 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2023-12-14 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2023-05-30 | Eingeleitet | William Blair | Outperform |
| 2023-05-04 | Fortgesetzt | Piper Sandler | Overweight |
| 2023-03-21 | Eingeleitet | Bernstein | Outperform |
| 2023-01-18 | Eingeleitet | Canaccord Genuity | Hold |
| 2023-01-17 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-12-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-06-01 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-05-06 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-03 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2022-02-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-01-27 | Bestätigt | JP Morgan | Overweight |
| 2022-01-27 | Bestätigt | Morgan Stanley | Underweight |
| 2022-01-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Hold |
| 2022-01-27 | Bestätigt | Wolfe Research | Outperform |
| 2022-01-20 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-09-09 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-07 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-07-20 | Herabstufung | SVB Leerink | Mkt Perform → Underperform |
| 2021-07-19 | Fortgesetzt | Wolfe Research | Outperform |
| 2021-07-01 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-11 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-02-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-02-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-30 | Eingeleitet | Daiwa Securities | Outperform |
| 2020-11-30 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-20 | Eingeleitet | Bernstein | Outperform |
| 2020-10-28 | Eingeleitet | UBS | Buy |
| 2020-07-31 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-03-04 | Eingeleitet | Barclays | Overweight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-11-19 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-09-03 | Hochstufung | Goldman | Neutral → Buy |
| 2019-08-01 | Herabstufung | Needham | Buy → Hold |
| 2019-05-23 | Fortgesetzt | Citigroup | Buy |
| 2019-05-21 | Eingeleitet | Credit Suisse | Outperform |
| 2019-04-12 | Eingeleitet | Evercore ISI | In-line |
| 2019-03-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2019-03-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-02-06 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
Vertex Pharmaceuticals Inc Aktie (VRTX) Neueste Nachrichten
Voya Investment Management LLC Has $168.85 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Montecito Bank & Trust Buys Shares of 2,239 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Is Vertex Pharmaceuticals Incorporated stock attractive after correctionQuarterly Trade Summary & Daily Stock Trend Reports - Bölüm Sonu Canavarı
Is Vertex Pharmaceuticals Incorporated stock positioned well for digital economy2025 Technical Patterns & Weekly Breakout Watchlists - Улправда
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Ipswich Investment Management Co. Inc. - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Sells 2,487 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Czech National Bank Increases Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
How analysts rate Vertex Pharmaceuticals Incorporated stock todayEarnings Miss & Reliable Intraday Trade Plans - Улправда
Vertex Pharmaceuticals Incorporated $VRTX Stake Lessened by Channel Wealth LLC - MarketBeat
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Corient Private Wealth LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Best Biotech Stocks To Watch NowDecember 16th - MarketBeat
Vertex, Inc. (VERX) Stock News Today: Latest Price, AI Tax Automation Updates, Analyst Forecasts and Outlook (Dec. 16, 2025) - ts2.tech
Texas Permanent School Fund Corp Sells 9,892 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Shorepoint Capital Partners LLC Invests $4.08 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
12 Days of Investing: My Top 12 Stocks to Buy Before 2026 - The Motley Fool
National Bank of Canada FI Acquires 99,751 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Castleark Management LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
B. Riley Wealth Advisors Inc. Buys Shares of 4,141 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
What's Driving the Market Sentiment Around Vertex Pharmaceuticals Inc? - Sahm
Vertex Pharmaceuticals (VRTX) Stock: What to Know Before the Market Opens on Dec. 15, 2025 - ts2.tech
MASTERINVEST Kapitalanlage GmbH Purchases Shares of 5,784 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Stake Increased by Westwood Holdings Group Inc. - MarketBeat
Lazard Asset Management LLC Has $213.83 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Provident Investment Management Inc. Raises Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Position Lifted by Liontrust Investment Partners LLP - MarketBeat
Marex Group plc Invests $2.98 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Coppell Advisory Solutions LLC Buys 2,846 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Is Vertex Pharmaceuticals Fairly Priced After Recent Gains and Expanding Pipeline in 2025? - Yahoo Finance
How Investors Are Reacting To Vertex Pharmaceuticals (VRTX) Pediatric CASGEVY Data And Accelerated FDA Review - Yahoo Finance
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX is Bellevue Group AG's 8th Largest Position - MarketBeat
2 Healthcare Stocks to Buy Ahead of the New Year - Finviz
Investors heavily search Vertex Pharmaceuticals Incorporated (VRTX): Here is what you need to know - MSN
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance
Sei Investments Co. Has $132.41 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
CIBC Asset Management Inc Sells 4,393 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Boosts Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - Finviz
Alliancebernstein L.P. Has $1.95 Billion Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025) - ts2.tech
United States Orphan Drugs Market to Reach USD 486.51 Billion - openPR.com
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $515.00 at Wells Fargo & Company - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Investment Management Corp of Ontario - MarketBeat
This Week’s CGT News: Vertex’s Gene Therapies Show Promise in Younger Children - The Medicine Maker
Wells Fargo Adjusts PT on Vertex Pharmaceuticals to $515 From $460, Maintains Overweight Rating - marketscreener.com
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Jump Financial LLC - MarketBeat
Ossiam Has $2.05 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Diadema Partners LP Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Bank of Nova Scotia Raises Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
State Street Corp Has $5.24 Billion Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Finanzdaten der Vertex Pharmaceuticals Inc-Aktie (VRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):